Results
26,520 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $75K 868 sh | Jan 14, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 868 sh | Jan 14, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 775 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $53K 637 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 2,105 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 776 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | Saba Capital Management, L.P.10% Owner |  GFNEW GERMANY FUND INCOpen-market sale | SELL | $24K 2,000 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $122K 1,328 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 869 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Papadopoulos DidierPresident of Aircraft OEM |  JOBYJoby Aviation, Inc.Open-market sale · 10b5-1 plan | SELL | $20K 1,367 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $31K 85 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $745 2 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $5,242 14 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $44K 123 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Nagendran SukumarDirector, President and Head of R&D |  TSHATaysha Gene Therapies, Inc.Open-market sale · 10b5-1 plan | SELL | $942K 200.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $17K 47 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Tuffin PaulaGeneral Counsel and CCO |  BETRBetter Home & Finance Holding CoOpen-market sale · 10b5-1 plan | SELL | $297K 7,698 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 42 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $7,047 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $7,137 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $35K 98 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 19 | Bowles GregoryChief Policy Officer | JOBYJoby Aviation, Inc. Open-market sale · 10b5-1 plan | SELL | $79K 5,383 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 19 | Piskel KyleChief Financial Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $77K 4,290 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 19 | Kao John EDirector, Chief Executive Officer |  ALHCAlignment Healthcare, Inc.Open-market sale · 10b5-1 plan | SELL | $59K 2,727 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 512 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $13K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1,459 18 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $6,824 80 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $8,290 91 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $827 9 sh | Jan 14, 2026 traded Jan 12, 2026 |